Deep initial Mohs stage for scalp cutaneous squamous cell carcinoma to avoid occult tumor - 13/03/20
Key words : biopsy, cutaneous squamous cell carcinoma, depth, dermatologic surgery, histopathology, Mohs micrographic surgery, Mohs stage, squamous cell carcinoma
Plan
Funding sources: None. |
|
Conflicts of interest: Dr Geronemus discloses medical advisory board for Allergan, Candela, Cearna, Cynosure, Cytrellis, Lutronics, and Soliton; investigator for Allergan, ArchiMedus, Avava, Candela, Cynosure, Cytrellis, Endo Pharmaceuticals, Galderma, Kerastem, Lutronic, Merz, New York Stem Cell Foundation, Pulse Biosystem, Revance, Sciton, and Sienna Labs; and stockholder for Cytrellis. Drs Lederhandler, Stokar, and Meehan have no conflicts of interest to declare. |
|
IRB approval status: Not applicable. |
Vol 82 - N° 4
P. e129-e130 - avril 2020 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?